Free Trial

Braskem (NYSE:BAK) Releases Quarterly Earnings Results, Beats Expectations By $0.27 EPS

Braskem logo with Energy background

Braskem (NYSE:BAK - Get Free Report) posted its earnings results on Monday. The company reported $0.30 EPS for the quarter, topping the consensus estimate of $0.03 by $0.27, Zacks reports. Braskem had a negative net margin of 9.88% and a negative return on equity of 439.59%. The firm had revenue of $3.60 billion during the quarter, compared to analysts' expectations of $22.86 billion.

Braskem Stock Up 5.1%

Shares of BAK stock opened at $3.81 on Tuesday. The company has a 50 day moving average price of $3.64 and a 200-day moving average price of $4.30. Braskem has a 52 week low of $2.85 and a 52 week high of $7.96. The firm has a market capitalization of $1.52 billion, a PE ratio of -1.07 and a beta of 1.83.

Analysts Set New Price Targets

Separately, Scotiabank cut shares of Braskem from a "sector outperform" rating to a "sector perform" rating in a research report on Monday, March 3rd.

Read Our Latest Analysis on BAK

Braskem Company Profile

(Get Free Report)

Braskem SA, together with its subsidiaries, produces and sells thermoplastic resins. The company operates through three segments: Brazil, United States and Europe, and Mexico. The Brazil segment produces and sells olefins, including ethylene, polymer and chemical grade propylene, butadiene, and butene-1; benzene, toluene, and xylenes products; fuels, such as automotive gasoline, liquefied petroleum gas, ethyl tertiary-butyl ether, and methyl tertiary-butyl ether; intermediates, such as cumene; aliphatics, aromatics, and hydrogenated solvents; and specialties comprising isoprene, dicyclopentadiene, piperylene, nonene, tetramer, polyisobutylene, and hydrocarbon resins.

Read More

Earnings History for Braskem (NYSE:BAK)

Should You Invest $1,000 in Braskem Right Now?

Before you consider Braskem, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Braskem wasn't on the list.

While Braskem currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Goldman Sachs Warns of 20% Market Drop—Are They Right?
Top 3 Insider Stock Buys in April—Are They Still Good in May?
5 Blowout Earnings Winners That Could Soar Even Higher

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines